InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Arsenault Kaitlyn. Director active across 1 company, notably Skye Bioscience, Inc.. Cumulatively, 7 reports have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €207k. Activity tracked since 25 August 2023. The latest transaction was filed on 15 November 2024 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
ARSENAULT KAITLYN is Chief Financial Officer at Skye Bioscience, Inc. The record shows 7 filings in total. Across the 7 sampled filings, they cover the period from 2023-08-29 to 2025-02-28, with EUR 0 of buys and EUR 206676 of sells, and the modal transaction nature is Attribution.